Therapeutics Cell Production

Workflow Optimization From Research to Commercialization

Sterile-Filtered Buffers, Media, Reagents, and Solutions

Therapeutic cell manufacturing relies on controlled process materials throughout cell isolation, culture, expansion, harvest, formulation, and cryopreservation. Media, wash buffers, supplements, processing solutions, and cryopreservation formulations are integral to maintaining cell viability and consistent process performance. Each material must meet defined formulation, quality, testing, documentation, and manufacturing requirements appropriate to the process.

Biologos manufactures ready-to-use solutions to customer-defined specifications, with packaging options compatible with closed-system workflows. Production capabilities support materials used from early feasibility and process development through scale-up and commercial manufacturing, helping simplify preparation and reduce the operational burden associated with in-house solution production.

Manufacturing Flexibility for Cell Therapy Programs

Therapeutic cell manufacturing processes can require specific formulations, raw materials, and packaging configurations based on the process design and stage of development. Requirements may change as a process moves from feasibility through scale-up, making flexibility in formulation and manufacturing important to long-term program support.

Biologos works with customers to establish manufacturing approaches that align with defined process requirements. Solutions may include customer-specified formulations, established ready-to-use products, specialized raw materials, or custom packaging configurations. Formulation and production parameters can be evaluated with consideration for performance, manufacturability, lead time, and cost.

Therapeutic Cell Product Offerings

Biologos provides sterile-filtered process materials for therapeutic cell manufacturing, including media, buffers, reagents, and specialized solutions. Filtration methods can include 0.2 µm or 0.1 µm filtration based on product characteristics and process requirements.

Packaging can be configured for the intended manufacturing environment, including rigid containers, bags, single-use bioprocess containers, and customer-specific closed-system configurations. Fill volumes and batch sizes can be established to accommodate the material requirements of development programs, process scale-up, and commercial production.

Cryopreservation Media

Cryopreservation media and other customer-defined formulations used during freezing, storage, thawing, and related cell-processing steps. Manufactured to specified composition with required parameters controlled as applicable.

Process and Wash Buffers

Wash, dilution, and other process buffers used throughout cell handling and manufacturing. Buffers are manufactured to the defined composition, with required parameters such as pH, conductivity, and osmolality controlled as applicable.

Science, Quality, Partnership

Why Biologos? A combination of technical expertise, rigorous quality systems, and flexible manufacturing supports consistent products, controlled processes, and reliable supply for therapeutic cell manufacturing customers.

Direct Access to
Technical Experts

Experienced support encompassing the entire project lifecycle.

Project
Flexibility

Supporting specification development, product transfers, and manufacturing requirements.

Disciplined Process
Management

Adherence to established document, quality, and manufacturing controls.

Supply Consistency
and Reliability

Scalability and supply assurance to support evolving needs.

Packaging Built for
Your Workflow

Bottles, bulk containers, or custom single-use assemblies, tailored packaging, labeling, and delivery to integrate into your operations.

Quality and Compliance at Every Stage

Quality is embedded throughout the manufacturing process, with every batch produced under an ISO 13485-certified quality management system and released against defined specifications. Complete lot traceability and a Certificate of Analysis (CoA) accompany each batch, while testing is established according to product specifications and customer requirements and may include pH, osmolality, conductivity, bioburden, endotoxin, sterility, identity, and other product-specific methods.

Documented change control and traceability extend from raw materials and components through packaging and finished products, maintaining visibility and control throughout the manufacturing process.

Yes. Container selection depends on more than fill volume. Product compatibility, storage conditions, sterile connections, dispensing method, shipping requirements, and how the product will be introduced into your manufacturing process all influence the right packaging configuration. We work with customers to develop practical solutions that fit their manufacturing processes.

Yes. Many customers work with us to reduce in-house solution preparation, minimize handling steps, consolidate compatible processing components into ready-to-use formulations, and optimize packaging configurations for their manufacturing process. By reducing the number of raw materials, suppliers, preparation steps, sterile transfers, inventory items, and manufacturing activities managed internally, we simplify day-to-day manufacturing and improve operational efficiency.

Yes. Where formulation compatibility has been established, we manufacture customer-defined ready-to-use formulations that can combine compatible proteins, growth factors, supplements, antibiotics, and other customer-specified components into a single sterile product. This helps reduce the need for in-house weighing, supplementation, mixing, sterile filtration, and other preparation steps.

Yes. Many therapeutic cell manufacturing programs involve internal manufacturing, multiple facilities, or one or more CDMO partners. We routinely coordinate packaging configurations, documentation, inventory, and product deliveries to support each stage of the manufacturing process.

Yes. We support products from early feasibility and process development through clinical and commercial manufacturing. As your process evolves, we adapt batch sizes, packaging configurations, testing, and documentation to support changing manufacturing requirements while providing continuity with the same manufacturing partner.

Both. Most of what we manufacture is produced from customer-owned formulations. We reproduce your formulation, processing requirements, packaging configuration, testing requirements, and documentation to support consistent manufacturing from lot to lot. We also manufacture standard products and recognized published formulations.

Yes. We manufacture xeno-free, serum-free, chemically defined, and other customer-specified formulations to support a wide range of therapeutic cell manufacturing processes.

Yes. We manufacture both DMSO-based and DMSO-free cryopreservation media. Because cryoprotectant selection is highly application-specific, the appropriate formulation depends on your cell type, manufacturing process, and performance requirements.

Yes. Products are available in bottles, bags, single-use bioprocess containers, tubing assemblies, sterile connectors, and other customer-defined packaging configurations tailored to how the product will be stored, transferred, connected, and used in your manufacturing process.

We manufacture classical and custom cell culture media, balanced salt solutions, xeno-free and animal-free media components, media supplements, growth factors, antibiotic additives, chemically defined feeds, cell isolation and selection buffers, activation and expansion media, wash buffers, harvest buffers, formulation buffers, cryopreservation media, microbiological media, process simulation media, sanitization buffers, and other customer-specific process formulations used throughout therapeutic cell manufacturing.

CAR-T, NK, T-cell, MSC, iPSC-derived, and other therapeutic cell types, across both autologous and allogeneic programs.

Experience That Supports Your Goals

Every project begins with a clear understanding of the formulation, timeline, specifications, and production requirements. Technical expertise and collaborative planning help establish an effective manufacturing approach, supporting a seamless transition from product development through commercial production.

Request a Custom Quote